In silico drug repurposing framework predicts repaglinide, agomelatine and protokylol as trpv1 modulators with analgesic activity

HIGHLIGHTS

SUMMARY

    The decoys were extracted from ChEMBL and were chosen based on common molecular descriptors widely used for describing drug-likeness, such as the molecular weight (MW), the logarithm of octanol/water partition_coefficient (logP), the number of hydrogen_bond donors (HBD) and the number of hydrogen_bond acceptors (HBA). The repurposing model was a multi-class classification algorithm based on a multilayer perceptron neural_network (MLP NN) and was trained to discriminate not only between active and inactive molecules but also between TRPV1 agonists and antagonists. The machine_learning algorithm that the authors selected for task was the multilayer . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?